Advertisement

Combination Therapy of Cutaneous T Cell Lymphoma with Interferon Alpha-2a and Photochemotherapy

  • R. Stadler
  • H. G. Otte
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 139)

Abstract

The efficacy of a combination treatment with interferon alpha-2a and photochemotherapy was investigated in 16 patients with cutaneous T cell lymphoma. During the initial treatment, interferon alpha-2a was given subcutaneously at maximum dose of 9 million IU. Simultaneously, photo-chemotherapy with a maximum single dose of 3.0 J/cm2 was applied. After a complete or partial remission had been achieved, the dose of interferon was continued as permanent treatment at 3–9 million IU a week. Photo-chemotherapy was maintained twice a week for a minimum of 2 months and then stopped depending on the course of the disease. The combination treatment was well tolerated and all patients responded to the initial therapy. Three patients were withdrawn at an early stage of therapy, as they developed erythrodermia after photochemotherapy. The permanent treatment led to a complete remission in ten out of 13 patients and to a partial remission in three patients. During the follow-up period (now 10–40 months), therapy was stopped in four patients because of progression and in one patient because of newly diagnosed Hodgkin’s disease. In another three patients, who developed local recurrences, a repetition of the initial treatment schedule was necessary to keep them in remission.

Keywords

Complete Remission Partial Remission Mycosis Fungoides Interferon Therapy Interferon Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Braathen LR, McFadden N (1989) Successful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alpha-2a. J Dermatol Treat 1:29–32CrossRefGoogle Scholar
  2. Bunn PA Jr, Foon KA, Ihde DC et al (1984) Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 101:484–487PubMedGoogle Scholar
  3. Bunn PA, Lamberg SI (1979) Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725–728PubMedGoogle Scholar
  4. Bunn PA, Norris DA (1990) The role of interferons and monoclonal antibodys in cutaneous T-cell lymphomas. J Invest Dermatol 95:209S-212SPubMedCrossRefGoogle Scholar
  5. Dreno B, Godefroy WY, Fleischmann M, Bureau B, Litoux P (1989) Low-dose recombinant interferon-alpha in the treatment of cutaneous T-cell lymphomas. Br J Dermatol 121:543–544PubMedCrossRefGoogle Scholar
  6. Gilchrest BA, Parish JA, Tannenbaum LR, Haynes Fitzpatrick TB (1976) Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 38:683–698PubMedCrossRefGoogle Scholar
  7. Holloway KB, Flowers FP, Ramos-Caro FA (1992) Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 27:367–378PubMedCrossRefGoogle Scholar
  8. Kuzel TM, Gilyon K, Springer E, Variakojis D, Kaul K, Bunn PA, Evans L, Roenigk HH, Rosen ST (1990) Interferon alpha-2a combined with photochemotherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82(3):203–207PubMedCrossRefGoogle Scholar
  9. Otte HG, Herges A, Stadler R (1992) Kombinationstherapie mit Interferon alfa 2a und PUVA bei kutanen T-Zell-Lymphomen. Hautarzt 43:695–699PubMedGoogle Scholar
  10. Roenigh HH, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Vaiakojis D, Kaul K, Bunn PA, Evans L, Rosen ST (1990) Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95:198S–205SCrossRefGoogle Scholar
  11. Simoni R, Cavalieri R, Coppola G, Ricciotti L, De Pita O, Criscuolo D, Covelli A, Papa G, Mandelli F (1987) Recombinant leukocyte interferon alpha-2a in the treatment of mycosis fungoides. J Biol Regul Homeost Agents 1:93–99PubMedGoogle Scholar
  12. Stadler R, Mayer-Da-Silva A, Bratzke B, Garbe C, Orfanos C (1989) Interferons in dermatology. J Am Acad Dermatol 20:650–656PubMedCrossRefGoogle Scholar
  13. Threstrup-Pedersen K, Hammer R, Kaltoft K, Sogaard H, Zachariae H (1988) Treatment of mycosis fungoides with recombinant interferon alpha-2a alone an in combination with etretinate. Br J Dermatol 118:811–818CrossRefGoogle Scholar
  14. Vonderheid EC, Thompson R, Smiles KA, Lattanand A (1987) Recombinant interferon alpha-2b in plaque-phase mycosis fungoides. Arch Dermatol 123: 757–763PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1995

Authors and Affiliations

  • R. Stadler
    • 1
  • H. G. Otte
    • 1
  1. 1.Department of Dermatology, Minden Medical CenterTeaching Unit of the University of MünsterMindenGermany

Personalised recommendations